Sproxil: Combating Counterfeit Drugs with Mobile Phones

Sproxil joined the Business Call to Action with a commitment to mobilize US$4 million to expand its efforts to empower patients and consumers in the fight against counterfeit medication in India and Kenya. In this Business Call to Action case study, learn more about how the company is promoting improved health care outcomes in key markets.

Download Case Study: English